Article ID: 9d7ab93996e53e8d71ba756b5f12309d96c8265006e30a47f8ca93368c76b0aa
Source ID: primary:newsnow.co.uk
Published At: -
Extraction Method: trafilatura
URL: http://newsnow.co.uk/h/UK/Health/Meningitis
Body Text
About our Meningitis news Latest news on meningitis, covering outbreaks, symptoms, NHS vaccines, treatment, septicaemia, sepsis, MenB, MenACWY, and UK and global developments. Meningitis is an inflammation of the protective membranes surrounding the brain and spinal cord, most commonly caused by viral or bacterial infection. While viral meningitis is usually less severe, bacterial meningitis — often caused by the bacterium Neisseria meningitidis — can be life-threatening and requires urgent medical treatment. Meningococcal disease remains a significant public health concern in the UK, with hundreds of confirmed cases of invasive meningococcal disease reported each year. Globally, meningitis causes an estimated 250,000 deaths annually, with the heaviest burden falling on sub-Saharan Africa and south Asia. The seriousness of meningitis was underscored in March 2026, when an outbreak of invasive meningococcal disease in the Canterbury area of Kent resulted in multiple deaths and hospitalisations linked to student populations. The UK Health Security Agency (UKHSA) led the response, distributing antibiotics to thousands of students at the University of Kent and advising anyone who had visited a Canterbury nightclub in the days before the outbreak to come forward. The incident prompted renewed calls from charities for wider vaccination of teenagers and young adults, highlighting the ongoing vulnerability of this age group. Recognising the symptoms of meningitis early is critical, as the disease can progress from mild signs to a life-threatening emergency within hours. Key symptoms include a sudden high fever, severe headache, stiff neck, sensitivity to light, vomiting, confusion, and cold hands and feet. Septicaemia can cause a characteristic rash that does not fade when pressed with a glass — the well-known "glass test". Early symptoms are easily mistaken for common illnesses such as flu, which is why awareness campaigns stress the importance of seeking immediate medical help by calling 999 or attending A&E if meningitis or sepsis is suspected. The UK's NHS vaccination programme offers protection against several strains of meningococcal bacteria. The MenB vaccine (Bexsero) has been part of the routine infant immunisation schedule since 2015, currently given at 8 weeks, 12 weeks, and one year. The MenACWY vaccine is offered to teenagers around age 14 and provides protection against four meningococcal groups. However, significant gaps remain: anyone born before 2015 is largely unvaccinated against MenB unless they have paid privately, and no NHS MenB booster is currently available for adolescents. The Joint Committee on Vaccination and Immunisation (JCVI) has so far concluded that routine MenB vaccination for teenagers is not cost-effective, a position that remains the subject of intense debate. Teenagers and young adults are among the groups most vulnerable to meningococcal disease, partly because up to one in four carry the bacteria harmlessly in the back of their throats and can unknowingly transmit it through close contact such as coughing, kissing, or sharing drinks. University environments, with their dense social mixing, create conditions where the bacteria can spread rapidly. Charities including Meningitis Now and the Meningitis Research Foundation play a central role in raising awareness, supporting affected families, and campaigning for expanded vaccine access. Meningitis Now's "No Plan B for MenB" campaign calls for a teenage booster programme and wider availability of the MenB vaccine on the high street at a fair price. The history of meningitis prevention is one of remarkable progress. The introduction of the Hib vaccine in 1992 dramatically reduced what was then the most common cause of bacterial meningitis in young children, while the MenC programme launched in 1999 virtually eliminated group C disease. The WHO's "Defeating Meningitis by 2030" roadmap, adopted in 2021, sets ambitious global targets including a 50% reduction in vaccine-preventable cases and a 70% reduction in deaths. Survivors of meningitis may face life-changing after-effects including hearing loss, limb amputation, and brain damage, underscoring the importance of both prevention and long-term support. World Meningitis Day, observed each October, serves as a focal point for global advocacy. Our NewsNow meningitis feed brings together the latest headlines from across the UK and beyond, covering outbreaks, vaccination policy, research breakthroughs, and personal stories. Whether you are a parent, a student heading to university, a healthcare professional, or simply want to stay informed about this serious disease, our feed provides comprehensive, constantly updated coverage from reliable sources.
Metadata (JSON)
{
"score": 11.65
}